{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:13:11Z","timestamp":1770747191012,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:00:00Z","timestamp":1356048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/eye.2012.256","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T10:43:17Z","timestamp":1356086597000},"page":"243-252","source":"Crossref","is-referenced-by-count":77,"title":["Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond"],"prefix":"10.1038","volume":"27","author":[{"given":"T","family":"Kivel\u00e4","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Kujala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"BFeye2012256_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ssu.10014","volume":"21","author":"LH Sobin","year":"2003","unstructured":"Sobin LH . TNM: evolution and relation to other prognostic factors. Semin Surg Oncol 2003; 21: 3\u20137.","journal-title":"Semin Surg Oncol"},{"key":"BFeye2012256_CR2","unstructured":"TNM Classification of Malignant Tumours 5th ed. Wiley: New York, 1997."},{"key":"BFeye2012256_CR3","unstructured":"TNM Classification of Malignant Tumours 6th ed. Wiley-Liss: New York, 2002."},{"key":"BFeye2012256_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0161-6420(02)01838-9","volume":"110","author":"PT Finger","year":"2003","unstructured":"Finger PT . Do you speak ocular tumor? Ophthalmology 2003; 110: 13\u201314.","journal-title":"Ophthalmology"},{"key":"BFeye2012256_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3322\/canjclin.54.3.131","volume":"54","author":"CM Balch","year":"2004","unstructured":"Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004; 54: 131\u2013149.","journal-title":"CA Cancer J Clin"},{"key":"BFeye2012256_CR6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.5858\/133.8.1197","volume":"133","author":"PT Finger","year":"2009","unstructured":"Finger PT . The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch Pathol Lab Med 2009; 133: 1197\u20131198.","journal-title":"Arch Pathol Lab Med"},{"key":"BFeye2012256_CR7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.5858\/133.8.1262","volume":"133","author":"SE Coupland","year":"2009","unstructured":"Coupland SE, White VA, Rootman J, Damato B, Finger PT . A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med 2009; 133: 1262\u20131267.","journal-title":"Arch Pathol Lab Med"},{"key":"BFeye2012256_CR8","unstructured":"Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange J-D et al. Staging of ciliary body and choroidal melanoma based on anatomic extent: a collaborative study by the European Ophthalmic Oncology Group. J Clin Oncol, (in press)."},{"key":"BFeye2012256_CR9","volume-title":"AJCC Cancer Staging Manual","author":"SE Edge","year":"2010","unstructured":"Edge SE, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AIII (eds) AJCC Cancer Staging Manual 7th ed. Springer: New York, 2010."},{"key":"BFeye2012256_CR10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.5858\/133.8.1256","volume":"133","author":"DJ Ainbinder","year":"2009","unstructured":"Ainbinder DJ, Esmaeli B, Groo SC, Finger PT, Brooks JP . Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer-International Union Against Cancer staging manual. Arch Pathol Lab Med 2009; 133: 1256\u20131261.","journal-title":"Arch Pathol Lab Med"},{"key":"BFeye2012256_CR11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.5858\/133.8.1268","volume":"133","author":"J Rootman","year":"2009","unstructured":"Rootman J, White VA . Changes in the 7th edition of the AJCC TNM classification and recommendations for pathologic analysis of lacrimal gland tumors. Arch Pathol Lab Med 2009; 133: 1268\u20131271.","journal-title":"Arch Pathol Lab Med"},{"key":"BFeye2012256_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.preteyeres.2011.05.003","volume":"30","author":"B Damato","year":"2011","unstructured":"Damato B, Eleuteri A, Taktak AF, Coupland SE . Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res 2011; 30: 285\u2013295.","journal-title":"Prog Retin Eye Res"},{"key":"BFeye2012256_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archophthalmol.2011.286","volume":"130","author":"S Khan","year":"2012","unstructured":"Khan S, Finger PT, Yu GP, Razzaq L, Jager MJ, de Keizer RJ et al. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol 2012; 130: 57\u201364.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012256_CR14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ophtha.2004.11.063","volume":"112","author":"E Kujala","year":"2005","unstructured":"Kujala E, Kivela T . Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma: evaluation of the 6th edition and future directions. Ophthalmology 2005; 112: 1135\u20131144.","journal-title":"Ophthalmology"},{"key":"BFeye2012256_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0008-4182(04)80004-8","volume":"39","author":"IW McLean","year":"2004","unstructured":"McLean IW, Saraiva VS, Burnier MN . Pathological and prognostic features of uveal melanomas. Can J Ophthalmol 2004; 39: 343\u2013350.","journal-title":"Can J Ophthalmol"},{"key":"BFeye2012256_CR16","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1111\/j.1755-3768.2009.01769.x","volume":"89","author":"M Angi","year":"2011","unstructured":"Angi M, Damato B, Kalirai H, Dodson A, Taktak A, Coupland SE . Immunohistochemical assessment of mitotic count in uveal melanoma. Acta Ophthalmol 2011; 89: e155\u2013e160.","journal-title":"Acta Ophthalmol"},{"key":"BFeye2012256_CR17","first-page":"1160","volume":"42","author":"A Moshari","year":"2001","unstructured":"Moshari A, McLean IW . Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections. Invest Ophthalmol Vis Sci 2001; 42: 1160\u20131163.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR18","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1167\/iovs.02-1215","volume":"44","author":"RT Al-Jamal","year":"2003","unstructured":"Al-Jamal RT, M\u00e4kitie T, Kivel\u00e4 T . Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body. Invest Ophthalmol Vis Sci 2003; 44: 2381\u20132389.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR19","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0161-6420(93)31470-3","volume":"100","author":"R Folberg","year":"1993","unstructured":"Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe\u2019er J et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993; 100: 1389\u20131398.","journal-title":"Ophthalmology"},{"key":"BFeye2012256_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/jnci\/91.4.359","volume":"91","author":"T M\u00e4kitie","year":"1999","unstructured":"M\u00e4kitie T, Summanen P, Tarkkanen A, Kivel\u00e4 T . Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst 1999; 91: 359\u2013367.","journal-title":"J Natl Cancer Inst"},{"key":"BFeye2012256_CR21","first-page":"2900","volume":"56","author":"AJ Foss","year":"1996","unstructured":"Foss AJ, Alexander RA, Jefferies LW, Hungerford JL, Harris AL, Lightman S . Microvessel count predicts survival in uveal melanoma. Cancer Res 1996; 56: 2900\u20132903.","journal-title":"Cancer Res"},{"key":"BFeye2012256_CR22","first-page":"2471","volume":"40","author":"T M\u00e4kitie","year":"1999","unstructured":"M\u00e4kitie T, Summanen P, Tarkkanen A, Kivel\u00e4 T . Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 1999; 40: 2471\u20132480.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR23","first-page":"2533","volume":"43","author":"X Chen","year":"2002","unstructured":"Chen X, Maniotis AJ, Majumdar D, Pe\u2019er J, Folberg R . Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci 2002; 43: 2533\u20132539.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR24","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken MD, Worley LA, Ehlers JP, Harbour JW . Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004; 64: 7205\u20137209.","journal-title":"Cancer Res"},{"key":"BFeye2012256_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","volume":"12","author":"MD Onken","year":"2010","unstructured":"Onken MD, Worley LA, Tuscan MD, Harbour JW . An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 2010; 12: 461\u2013468.","journal-title":"J Mol Diagn"},{"key":"BFeye2012256_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/archophthalmol.2009.40","volume":"127","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE . Translating uveal melanoma cytogenetics into clinical care. Arch Ophthalmol 2009; 127: 423\u2013429.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012256_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ophtha.2010.05.023","volume":"118","author":"CL Shields","year":"2011","unstructured":"Shields CL, Ganguly A, Bianciotto CG, Turaka K, Tavallali A, Shields JA . Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Ophthalmology 2011; 118: 396\u2013401.","journal-title":"Ophthalmology"},{"key":"BFeye2012256_CR28","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1158\/1078-0432.CCR-06-2401","volume":"13","author":"LA Worley","year":"2007","unstructured":"Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH et al. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res 2007; 13: 1466\u20131471.","journal-title":"Clin Cancer Res"},{"key":"BFeye2012256_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/gcc.2870050304","volume":"5","author":"K Sisley","year":"1992","unstructured":"Sisley K, Cottam DW, Rennie IG, Parsons MA, Potter AM, Potter CW et al. Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer 1992; 5: 197\u2013200.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFeye2012256_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0165-4608(00)00266-1","volume":"122","author":"F Tschentscher","year":"2000","unstructured":"Tschentscher F, Prescher G, Zeschnigk M, Horsthemke B, Lohmann DR . Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 2000; 122: 13\u201317.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFeye2012256_CR31","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","volume":"16","author":"B Damato","year":"2010","unstructured":"Damato B, Dopierala JA, Coupland SE . Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010; 16: 6083\u20136092.","journal-title":"Clin Cancer Res"},{"key":"BFeye2012256_CR32","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1167\/iovs.09-5004","volume":"51","author":"J Dopierala","year":"2010","unstructured":"Dopierala J, Damato BE, Lake SL, Taktak AF, Coupland SE . Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci 2010; 51: 4898\u20134905.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR33","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1167\/iovs.09-5083","volume":"51","author":"SL Lake","year":"2010","unstructured":"Lake SL, Coupland SE, Taktak AF, Damato BE . Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci 2010; 51: 4884\u20134891.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/CMR.0b013e32834e6a67","volume":"22","author":"J Vaarwater","year":"2012","unstructured":"Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC et al. Multiplex ligation-dependent probe amplification equals fluorescence in situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Melanoma Res 2012; 22: 30\u201337.","journal-title":"Melanoma Res"},{"key":"BFeye2012256_CR35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2353\/jmoldx.2006.060077","volume":"8","author":"MD Onken","year":"2006","unstructured":"Onken MD, Worley LA, Davila RM, Char DH, Harbour JW . Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens. J Mol Diagn 2006; 8: 567\u2013573.","journal-title":"J Mol Diagn"},{"key":"BFeye2012256_CR36","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","volume":"119","author":"MD Onken","year":"2012","unstructured":"Onken MD, Worley LA, Char DH, Augsburger JJ, Correa ZM, Nudleman E et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology 2012; 119: 1596\u20131603.","journal-title":"Ophthalmology"},{"key":"BFeye2012256_CR37","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T . Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44: 4651\u20134659.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/cncr.11113","volume":"97","author":"S Eskelin","year":"2003","unstructured":"Eskelin S, Pyrh\u00f6nen S, Hahka-Kemppinen M, Tuomaala S, Kivel\u00e4 T . A prognostic model and staging for metastatic uveal melanoma. Cancer 2003; 97: 465\u2013475.","journal-title":"Cancer"},{"key":"BFeye2012256_CR39","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1111\/j.1600-0420.2007.01063_3573.x","volume":"85","author":"S ESKELIN","year":"2007","unstructured":"Eskelin S, Piperno-Neumann S, Desjardins L, Schmittel A, Bechrakis N, Midena E et al. Validating the Helsinki University Central Hospital (HUCH) working formulation for staging metastatic uveal melanoma. Acta Ophthalmol Scand (Suppl) 2007; 85 doi:10.1111\/j.1600-0420.2007.01063_3573.x.","journal-title":"Acta Ophthalmologica Scandinavica"},{"key":"BFeye2012256_CR40","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/archophthalmol.2011.2566","volume":"130","author":"YA Yousef","year":"2012","unstructured":"Yousef YA, Finger PT . Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma. Arch Ophthalmol 2012; 130: 599\u2013606.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012256_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/IOP.0b013e3182611670","volume":"28","author":"CL Shields","year":"2012","unstructured":"Shields CL, Kaliki S, Al-Dahmash SA, Lally SE, Shields JA . American Joint Committee on Cancer (AJCC) Clinical Classification Predicts Conjunctival Melanoma Outcomes. Ophthal Plast Reconstr Surg 2012; 28: 313\u2013323.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"BFeye2012256_CR42","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1001\/archopht.118.11.1497","volume":"118","author":"CL Shields","year":"2000","unstructured":"Shields CL, Shields JA, Gunduz K, Cater J, Mercado GV, Gross N et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000; 118: 1497\u20131507.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012256_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.86.2.163","volume":"86","author":"G Anastassiou","year":"2002","unstructured":"Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP . Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol 2002; 86: 163\u2013167.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012256_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/BF00448801","volume":"234","author":"JC Norregaard","year":"1996","unstructured":"Norregaard JC, Gerner N, Jensen OA, Prause JU . Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 1996; 234: 569\u2013572.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2012256_CR45","first-page":"3399","volume":"43","author":"S Tuomaala","year":"2002","unstructured":"Tuomaala S, Eskelin S, Tarkkanen A, Kivel\u00e4 T . Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci 2002; 43: 3399\u20133408.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1167\/iovs.04-0344","volume":"46","author":"GS Missotten","year":"2005","unstructured":"Missotten GS, Keijser S, de Keizer RJ, de Wolff-Rouendaal D . Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 2005; 46: 75\u201382.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012256_CR47","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0161-6420(02)00967-3","volume":"109","author":"S Tuomaala","year":"2002","unstructured":"Tuomaala S, Aine E, Saari KM, Kivel\u00e4 T . Corneally displaced malignant conjunctival melanomas. Ophthalmology 2002; 109: 914\u2013919.","journal-title":"Ophthalmology"},{"key":"BFeye2012256_CR48","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1442-9071.2008.01888.x","volume":"36","author":"B Damato","year":"2008","unstructured":"Damato B, Coupland SE . Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Experiment Ophthalmol 2008; 36: 786\u2013795.","journal-title":"Clin Experiment Ophthalmol"},{"key":"BFeye2012256_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/00002341-200111000-00010","volume":"17","author":"B Esmaeli","year":"2001","unstructured":"Esmaeli B, Eicher S, Popp J, Delpassand E, Prieto VG, Gershenwald JE . Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg 2001; 17: 436\u2013442.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"BFeye2012256_CR50","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ophtha.2003.11.001","volume":"111","author":"S Tuomaala","year":"2004","unstructured":"Tuomaala S, Kivel\u00e4 T . Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 2004; 111: 816\u2013821.","journal-title":"Ophthalmology"},{"key":"BFeye2012256_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/CMR.0b013e3282fafd21","volume":"18","author":"S Tuomaala","year":"2008","unstructured":"Tuomaala S, Kivel\u00e4 T . Sentinel lymph node biopsy guidelines for conjunctival melanoma. Melanoma Res 2008; 18: 235.","journal-title":"Melanoma Res"},{"key":"BFeye2012256_CR52","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/02713680701648019","volume":"32","author":"S Tuomaala","year":"2007","unstructured":"Tuomaala S, Toivonen P, Al-Jamal R, Kivel\u00e4 T . Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res 2007; 32: 939\u2013952.","journal-title":"Curr Eye Res"},{"key":"BFeye2012256_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/13816810802452168","volume":"30","author":"DE Novetsky","year":"2009","unstructured":"Novetsky DE, Abramson DH, Kim JW, Dunkel IJ . Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies\u2014an analysis of impact. Ophthalmic Genet 2009; 30: 40\u201344.","journal-title":"Ophthalmic Genet"},{"key":"BFeye2012256_CR54","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","volume":"113","author":"CL Shields","year":"2006","unstructured":"Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006; 113: 2276\u20132280.","journal-title":"Ophthalmology"},{"issue":"2","key":"BFeye2012256_CR55","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/eye.2012.175","volume":"27","author":"C L Shields","year":"2012","unstructured":"Shields CL, Fulco EM, Arias JD, Alarcon C, Pelligrini M, Rishi P et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond), e-pub ahead of print 21 September 2012; doi:10.1038\/eye.2012.175.","journal-title":"Eye"},{"key":"BFeye2012256_CR56","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ophtha.2008.10.014","volume":"116","author":"CL Shields","year":"2009","unstructured":"Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT et al. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology 2009; 116: 544\u2013551.","journal-title":"Ophthalmology"},{"key":"BFeye2012256_CR57","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/pbc.20606","volume":"47","author":"G Chantada","year":"2006","unstructured":"Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 2006; 47: 801\u2013805.","journal-title":"Pediatr Blood Cancer"},{"key":"BFeye2012256_CR58","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pbc.21278","volume":"50","author":"AY Schouten-van Meeteren","year":"2008","unstructured":"Schouten-van Meeteren AY, van der Valk P, Moll AC, Imhof SM, de Graaf P, Siregar NCh et al. International retinoblastoma staging system helps to bridge the gap. Pediatr Blood Cancer 2008; 50: 733.","journal-title":"Pediatr Blood Cancer"},{"key":"BFeye2012256_CR59","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1200\/JCO.1999.17.6.1829","volume":"17","author":"T Kivela","year":"1999","unstructured":"Kivela T . Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 1999; 17: 1829\u20131837.","journal-title":"J Clin Oncol"},{"key":"BFeye2012256_CR60","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/eye.2012.126","volume":"26","author":"B Damato","year":"2012","unstructured":"Damato B . Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture. Eye (Lond) 2012; 26: 1157\u20131172.","journal-title":"Eye (Lond)"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2012256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012256","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:41Z","timestamp":1684430261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2012256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFeye2012256"],"URL":"https:\/\/doi.org\/10.1038\/eye.2012.256","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}